title: Angiosarcoma of the scalp treated with OK-432 and rIL-2.
authors.affiliation: Department of Dermatology, Graduate School of Medicine, Osaka University, Japan. kanrou@mac.com
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Miura
authors.forename: Sigeki
authors.initials: S
authors.lastname: Inui
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Sakai
authors.forename: Nobushige
authors.initials: N
authors.lastname: Hasebe
authors.forename: Satoshi
authors.initials: S
authors.lastname: Itami
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Yoshikawa
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D010844:Picibanil / Q000008:administration & dosage / Q000627:therapeutic use*; D011995:Recombination, Genetic; D012535:Scalp / Q000187:drug effects* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2; D010844:Picibanil